Return to Article Details INTRAVENOUS FERRIC CARBOXYMALTOSE IN THE TREATMENT OF HEART FAILURE: EFFECTS ON PATIENTS WITH PRESERVED AND REDUCED EJECTION FRACTION Download Download PDF